DJIA 17,098.45 18.88 0.11%
NASDAQ 4,580.27 0.00 0.00%
S&P 500 2,003.37 6.63 0.33%
market minute promo

InterMune (NASDAQ: ITMN)

73.45 0.24 (0.33%)

REAL-TIME: Last trade at

Extended Hours: $73.46 $0.01 (0.01%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

ITMN $73.45 0.33%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $73.29
Previous Close $73.21
Daily Range $73.25 - $73.52
52-Week Range $10.95 - $73.52
Market Cap $7.9B
P/E Ratio -28.25
Dividend (Yield) $0.00 (0.0%)
Volume 6,523,521
Average Daily Volume 5,180,321
Current FY EPS -$2.72

Sector

Healthcare

Industry

Drugs

InterMune (ITMN) Description

The Company is a biotech company focused on developing and commercializing innovative therapies in pulmonology and hepatology. Website: http://www.intermune.com/

News & Commentary Rss Feed

Up 35% on Buyout: InterMune inc Investor Key Takeaways

FDA's rejection of InterMune's Esbriet hurt investors, but Roche clearly thinks the drug will be approved.

Will This Retail Stock Survive? (Podcast)

What You Need to Know About the Roche-InterMune Deal

Markets Reverse Early Morning Losses; Still Lower On The Day

Benzinga's Top Initiations

Biotech Stock Roundup: Biotechs Surge on InterMune Acquisition Deal, Focus on More M&As - Analyst Bl

Biotech Stock Roundup: Biotechs Surge on InterMune Acquisition Deal, Focus on More M&As - Analyst Blog

Roche, InterMune a Strategic Play in Midst of Inversions

Should you buy ISIS? No, not that one

Today In SA PRO: Tuesday, August 26

Roche Furthers Immunotherapy Program with SP142 Launch - Analyst Blog

With An Iffy Non-Oncology Pipeline, Roche Pays Up For InterMune

See More ITMN News...

ITMN's Top Competitors

ITMN $73.45 (0.33%)
Current stock: ITMN
AMGN $139.38 (0.50%)
Current stock: AMGN
GILD $107.56 (0.05%)
Current stock: GILD
BIIB $343.04 (0.53%)
Current stock: BIIB